Since its introduction, over 8,000 doctors have chosen Frequency Doubling Technology to quickly and accurately detect the early stages of visual field loss associated with glaucoma, and other eye diseases.
Welch Allyn patented Frequency Doubling Technology
Glaucoma Detection FDT
Now with expanded glaucoma management tools.
Building upon Frequency Doubling Technology, Humphrey® Matrix represents the latest advancement in clinically-validated glaucoma management.